Receptor of advanced glycation end-products axis and gallbladder cancer: A forgotten connection that we should reconsider

doi:10.3748/wjg.v28.i39.5679

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 39

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2918)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

187

WORD

HTML

1708

Figures (1-1)

171

Tables (1-1)

201

Sum=2309

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

207

Download

402

Sum=609

Oct 21, 2022 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Oct 21, 2022; 28(39): 5679-5690
Published online Oct 21, 2022. doi: 10.3748/wjg.v28.i39.5679

Receptor of advanced glycation end-products axis and gallbladder cancer: A forgotten connection that we should reconsider

Armando Rojas, Cristian Lindner, Iván Schneider, Ileana Gonzàlez, Miguel Angel Morales

Armando Rojas, Ileana Gonzàlez, Biomedical Research Laboratories, Catholic University of Maule, Talca 34600000, Maule, Chile

Cristian Lindner, Iván Schneider, Medicine Faculty, Catholic University of Maule, Talca 34600000, Maule, Chile

Miguel Angel Morales, Department of Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, University of Chile, Santiago 8320000, Santiago, Chile

Author contributions: All authors contributed to the original ideas and writing of this paper; Rojas A designed the report and wrote the paper; Lindner C artwork and data acquisition, drafting and revising the manuscript; Schneider I, Gonzalez I, and Morales MA, data acquisition, drafting and revising the manuscript.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Armando Rojas, PhD, Full Professor, Senior Scientist, Biomedical Research Labs, Catholic University of Maule, 3605, San Miguel Ave., Talca 34600000, Maule, Chile. arojasr@ucm.cl

Received: June 27, 2022
Peer-review started: June 27, 2022
First decision: August 1, 2022
Revised: August 5, 2022
Accepted: September 9, 2022
Article in press: September 9, 2022
Published online: October 21, 2022

Core Tip

Core tip: A growing body of data has demonstrated a positive association between the risk of gallbladder cancer and high dietary intake of advanced glycation end-products (AGEs). These noxious compounds are important contributors to the onset of a chronic inflammatory response, through the activation of the receptor of AGEs (RAGE). We herein discuss how RAGE activation is crucial in the development of gallbladder cancer and the relevance of new incoming data supporting the role of dietary interventions to reduce the risk of gallbladder cancer.